U.S. flag

An official website of the United States government

Here’s how you know
Here’s how you know

**Official websites use .gov**
A **.gov** website belongs to an official government organization in the United States.

**Secure .gov websites use HTTPS**
A **lock** ( A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Search Query:
			MAIN MENU

																				
              Health Topics
								All Health Topics A-Z
					
													
		

		Asthma


				

															Heart-Healthy Living


				

															High Blood Pressure


				

															Sickle Cell Disease


				

															Sleep Apnea


				

															Information & Resources on COVID-19
																				
              Health Education
								Education Programs and Initiatives
					
													
		

		The Heart Truth®


				

															Learn More Breathe Better®


				

															Blood Diseases and Disorders Education Program


				

															Publications and Resources
																				
              The Science
								Research Focus Areas
					
													
		

		Blood Disorders and Blood Safety


				

															Sleep Science and Sleep Disorders


				

															Lung Diseases


				

															Health Disparities and Inequities


				

															Heart and Vascular Diseases


				

															Precision Medicine Activities


				

															Obesity, Nutrition, and Physical Activity


				

															Population and Epidemiology Studies


				

															Women’s Health


				

															Research Topics


				

															Clinical Trials


				

															All Science A-Z
																				
              Grants and Training
								Grants and Training Home


				

															Policies and Guidelines


				

															Funding Opportunities and Contacts


				

															Training and Career Development
																				
              News and Events
								News and Events Home
					
													
		

		Email Alerts


				

															All News
					
													
		

		NHLBI News


				

															NHLBI in the Press


				

															Research Features


				

															All Events
					
													
		

		Past Events


				

															Upcoming Events
																				
              About NHLBI
								About NHLBI Home
					
													
		

		Mission and Strategic Vision


				

															Leadership


				

															Divisions, Offices and Centers


				

															Advisory Committees


				

															Budget and Legislative Information


				

															Jobs and Working at the NHLBI


				

															Contact and FAQs


				

															NIH Sleep Research Plan
						
						HOME
		Search Text: Home/< Back ToThe Science/Collaborating Network of Networks for Evaluating COVID-19 and Therapeutic Strategies (CONNECTS)

Collaborating Network of Networks for Evaluating COVID-19 and Therapeutic Strategies (CONNECTS)
                        
                                                Project began
            2020
              Website
            
                
            https://nhlbi-connects.org/
                                        On this page
                        Why is CONNECTS important?
                                                            How will CONNECTS contribute to COVID-19 scientific advances?
                                                            How does CONNECTS align with other COVID-19 programs?
                                                            What clinical trial networks are part of CONNECTS?
                                                            How can researchers access CONNECTS data?
                                                                                                                    Related Reading
        What is the goal of CONNECTS?
                        
            The NHLBI’s Collaborating Network of Networks for Evaluating COVID-19 and Therapeutic Strategies (CONNECTS) is an important and innovative research effort. The goal of CONNECTS is to build on NHLBI’s existing clinical research networks across the nation and around the world to better understand the risk of severe illness from COVID-19 and to identify therapies that will slow or halt the disease progression and speed recovery.
                Why is CONNECTS important?
    Coordinating and streamlining efforts under one organizational umbrella enables us to respond quickly and efficiently by promotingstandardization, collaboration, and sharing of resources and data. As part of this coordination, studies conducted under CONNECTS will use an adaptive design that will allow research to be quickly started, stopped, and adjusted as data emerges. In addition, we will leverage existing programs to expand community-based research and address the needs of at-risk populations at the community level.

Clinical trials usually test one intervention at a time within a single network of clinical trial sites. CONNECTS provides the opportunity to conduct adaptive trials across multiple networks. Researchers across these sites can test a variety of interventions simultaneously, sharing data and identifying the most—or least—promising treatments more quickly.

The CONNECTS studies will also enroll participants with health conditions, such as heart disease, high blood pressure, and chronic lung disease, that are known to increase their risk for severe complications from COVID-19.
              How will CONNECTS contribute to COVID-19 scientific advances?
    The CONNECTS initiative provides the infrastructure to implement the NHLBI’s COVID-19 research strategy. Through the initiative, the NHLBI is building a network of networks to quickly and efficiently investigate risk factors and potential therapies for COVID-19, and to rapidly share their results to help improve patient outcomes.

The interventions tested in CONNECTS trials will focus on:

**Targeting the virus itself.**Interventions such as monoclonal antibodies directly attack the virus to prevent it from infecting or multiplying. Another example of virus-targeted treatments uses plasma from people who have recovered from COVID-19 to try and build “passive” immunity in others who are at risk of a serious infection.
	**Targeting the body.**Called “host-targeted” treatments, these seek to  limit damage to the body from the viral infection. Examples of these are anticoagulants**,** which help break apart and prevent blood clots from forming in blood vessels, and immune modulators, which activate or suppress the immune system’s response to the virus.The Approaches to Prevent and Treat COVID-19 table features two rows and three columns including the type of treatment approach, how it works in the body, and examples of each. The virus-targeted approach targets the virus itself to prevent it from infecting or multiplying. Examples include monoclonal antibodies and hyperimmune globulin. Monoclonal antibodies target cells in the heart, lungs, blood, or blood vessels to reduce the impact of the virus on the body. Hyperimmune globulin uses plasma from people who have recovered from COVID-19 to try and build “passive” immunity in others who are at risk of a serious infection. Host-targeted approaches seek to limit damage to the body from the viral infection. Examples include anticoagulation therapies and immunomodulation. Anticoagulation therapies involve using medicines to break apart and prevent blood clots in veins and arteries. Immunomodulation involves using medicines to activate or suppress the immune system’s response to the virus.

The CONNECTS initiative will also leverage process, data, and biospecimens from existing observational cohort studies. This will help establish a cohort of cohorts that will study the characteristics of people who do and do not develop SARS-CoV-2, the virus that causes COVID-19. This can help us identify risk factors, inform strategies for prevention, and suggest biomarkers of infection to improve patient outcomes.
              How does CONNECTS align with other COVID-19 programs?
    The NHLBI will provide strategic direction, oversight, and key partnerships, in collaboration with the Department of Health and Human Service’s Biomedical Advanced Research and Development Authority (BARDA) and the federal partnership Operation Warp Speed; and other NIH Institutes and Centers, such as the National Institute of Allergy and Infectious Diseases (NIAID).

The CONNECTS initiative aims to:

**Integrate major NHLBI trial networks and observational cohort studies under one organizational umbrella.**This will help create a standard and efficient process for collaboration and sharing of data and resources.
	**Adopt a nimble and adaptive strategy** for shifting studies as needed, based on new knowledge and changing pandemic clinical landscape.
	**Align clinical trials with other trans-NIH efforts.** These include innovative, community-based interventions to work with vulnerable populations, data coordination, and collaboration with industry. NIH-led efforts include Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, which was created to prioritizeand speed development of the most promising COVID-19 treatments and vaccines.The clinical research that fall under the NHLBI-CONNECTS umbrella are among the first projects of thispublic-private partnership.A Steering Committee was established to provide oversight of the large group of networks and studies including:

Compliance with Program policies and procedures
	Design, implementation, and analysis of CONNECTS study protocols
	Interpretation and presentation of results in publications, press releases and scientific meetings
	Use of common data elements and data standards across CONNECTS study protocols
	Sharing of data, biospecimens, images, and other research products developed by CONNECTSA Data and Safety Monitoring Board (DSMB) monitors the safety of all CONNECTS ongoing trials.
              What clinical trial networks are part of CONNECTS?
    NHLBI-CONNECTS leverages existing clinical research networks across the nation and around the world, which allows us to test treatments with a wide variety of patient populations.

Some of the networks already involved and supporting studies include Prevention and Early Treatment of Acute Lung Injury (PETAL), Recipient Epidemiology and Donor Evaluation Study (REDS), and Strategies to Innovate Emergency Care (SIREN).
              How can researchers access CONNECTS data?
    CONNECTS research specimens and data will be shared on NHLBI’sBiologic Specimen and Data Repository Information Coordinating Center (BioLINCC)andBioData Catalystplatforms. Shared data are identified and can be accessed by researchers.
    Links and Resources
      
	-
		Collaborating Network of Networks for Evaluating COVID-19 and Therapeutic Strategies (CONNECTS)
    Get the latest research information from NIH
	Get the latest public health information from CDC
	Learn more about the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
	Learn more about the Rapid Acceleration of Diagnostics (RADx) initiative
	Join the fight against COVID-19 by participating in a late phase clinical trial or donating plasma at CombatCOVID.HHS.gov
                                Related Health Topics
                                    Clinical Trials Back To Top Link
  

        

        Back to top
  Web Policies & Notices
  

        

              Accessibility
                      No FEAR Act Data
                      Privacy Policy
                      Freedom of Information Act (FOIA)
                      HHS Vulnerability Disclosure
    
          Related Government Websites
  

        

              Health and Human Services
                      National Institutes of Health
                      Office of the Inspector General
                      USA.gov
    
          Stay Connected
    
      
            chat bubblesLive ChatLive Chat with us, Monday through Friday, 8:30 a.m. to 5:00 p.m. EST.envelopeGet Email AlertsReceive automatic alerts about NHLBI related news and highlights from across the Institute.
  Footer Bottom
  

        



Contact Us
                            Site Index
                            Jobs